Vanikar A V, Trivedi H L
Department of Pathology, Laboratory Medicine, Transfusion Services and Immunohematology, Institute of Transplantation Sciences, Ahmedabad, Gujarat, India.
Transplant Proc. 2007 Apr;39(3):773-8. doi: 10.1016/j.transproceed.2007.03.002.
Renal transplantation has achieved reasonably good success over the years in controlling acute rejection episodes; however, the immunology of chronic rejection is still not well understood. The problem haunts transplanters across the globe. We describe the presentation, brief immunopathological events, and recent advances suggested by pathologists to define chronic rejection and differentiate it from chronic allograft nephropathy. Our experience using tolerance induction is briefly mentioned including a reduced incidence of acute rejection episodes, chronic rejection events, or calcineurin inhibitor toxicity using lower drug levels.
多年来,肾移植在控制急性排斥反应方面取得了相当不错的成效;然而,慢性排斥反应的免疫学机制仍未得到充分了解。这个问题困扰着全球的移植医生。我们描述了慢性排斥反应的表现、简要的免疫病理过程,以及病理学家为定义慢性排斥反应并将其与慢性移植肾肾病相区分而提出的最新进展。我们还简要提及了使用诱导免疫耐受的经验,包括使用较低药物剂量时急性排斥反应、慢性排斥反应事件或钙调神经磷酸酶抑制剂毒性发生率的降低。